Image

Breaking Sitting with High-intensity Interval Training for Brain Health

Breaking Sitting with High-intensity Interval Training for Brain Health

Recruiting
40-75 years
All
Phase N/A

Powered by AI

Overview

This trial will examine whether interrupting 3.5 hours of sitting every 30 min with 6 min high intensity interval training (HIIT) breaks compared to light intensity interval training (LIIT) will improve brain health in cognitively normal older adults. This trial will test the feasibility of HIIT breaks to sitting. It will also address several important but unanswered questions: (1) Does interrupting sitting with short HIIT breaks improve frontoparietal function? (2) Can interrupting sitting with HIIT breaks improve cognitive functions?

Description

The investigators are conducting an acute, single site randomized crossover trial testing two conditions lasting 3.5 hours each with a one to four-weeks washout period: (1) Interrupting sitting with 6 min of high-intensity interval training (HIIT) every 30 min, and (2) interrupting sitting with 6-min light-intensity interval training (LIIT) every 30 min. Investigators will administer the conditions in a counterbalanced order to 54 older adults (40-75 years). Brain function will be assessed using event-related brain potentials and measures of functional connectivity derived from electroencephalography. Cognitive functions will be assessed using a modified Eriksen flanker task and an antisaccade task. Investigators will measure episodic memory using a mnemonic discrimination task.

Eligibility

Inclusion Criteria:

  1. Age 40-75 years
  2. BMI <40 kg/m2
  3. Sedentary (≥ 6 h/day sitting by a survey question)
  4. Physically inactive adults based on the CSEP-PATH: Physical Activity and Sedentayr Behaviour Questionnaire (PASB-Q) Adult (low or medium physical activity range equivalent to less than 300 min of moderate intensity physical activity per week)
  5. Capable of exercising vigorously based on the Physical Activity Readiness Questionnaire (PARQ+)
  6. Has a medical clearance for maximal exercise and HIIT from a physician
  7. Normotensive or participant's blood pressure is controlled
  8. Intelligence quotient (IQ) ≥85
  9. Fasting plasma glucose <126 mg/dL
  10. Good or corrected vision and hearing
  11. Right-handed
  12. No significant abnormalities on the ECG during the maximal exercise test
  13. No signs and symptoms that suggest an underlying cardiovascular disease as recorded during the maximal exercise test by a study physician.
  14. No indications to prematurely stop the maximal exercise test as outlined by the ACSM's Guidelines for Exercise Testing and Prescription
  15. Concussion if more than 12 months before the study screening.
  16. History of cancer but in full remission for at least 12 months and no history of chemotherapy, signed off by the physician or an oncologist

Exclusion Criteria:

  1. Physical disability or musculoskeletal disease prohibitive to vigorous exercise
  2. Learning disabilities
  3. Cognitive impairment (MoCA <26)
  4. Type 1 or 2 diabetes
  5. Neurological condition (e.g., Multiple Sclerosis, Parkinson, Dementia, Mild Cognitive Impairment)
  6. Color blindness
  7. Brain injury (e.g., traumatic brain injury, stroke, concussion)
  8. Migraine headaches
  9. Presence of other health conditions that may be exacerbated by exercise
  10. History of heart disease
  11. High cholesterol not controlled by medication
  12. Signs and symptoms indicative of underlying cardiovascular disease
  13. A chronic pulmonary disease
  14. Emphysema
  15. Pulmonary embolus
  16. Asthma
  17. History of renal disease
  18. History of seizures
  19. A neuropsychiatric disorder
  20. Osteoporosis if it interferes with an individual's ability to exercise
  21. Severe back problems
  22. Severe arthritis if it interferes with an individual's ability to exercise
  23. Thyroid disorder not controlled by medication
  24. Polyneuropathy
  25. Sleep disorders
  26. Acquired immunodeficiency syndrome (AIDS)
  27. Hepatitis C
  28. History of long Coronavirus Disease 2019 (COVID-19)
  29. History of cancer if not in full remission for at least 12 months and if a participant had the history of chemotherapy
  30. Current or past smoking <12 months
  31. Corticosteroid intake < 31 days before screening
  32. Opioids taken < 6 months from screening
  33. Anabolic androgens taken < 31 days before screening
  34. A serious illness or hospitalization in the last six months
  35. Currently taking medications that can affect the central nervous system (except for anxiolytics)
  36. Current participation in an ongoing trial likely to influence exercise ability or cognitive function

Study details
    Aging

NCT06243016

University of Illinois at Urbana-Champaign

21 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.